Canine parvovirus type 2 (CPV-2) causes a severe and highly contagious disease in dogs. A common manifestation of parvovirus infection is hemorrhagic enteritis. The disease can be prevented by vaccination and the CPV-2 vaccine is recommended as a core vaccine that should be given to all dogs.

We now provide a recombinant CPV-2 capsid protein VP2 which could be used
• As a calibrator in immunoassays for the detection of CPV
• As an antigen in CPV antibody titer analyses

The recombinant VP2 is expressed in a eukaryotic cell line. It consists of 584 amino acid residues and does not contain any affinity tags. The protein is able to assemble into virus-like particles (VLPs, see Figure 1).


Figure 1. Electron micrographs of CPV virus-like particles that are produced by the expression of the recombinant VP2 protein.

Figure 2. The antigen is recognized by our anti-CPV antibodies (Cat. # 3PV16). The calibration curve for the 5G7-8H7 immunoassay using recombinant CPV capsid protein VP2 as the antigen.


Figure 3. SDS-PAGE of recombinant VP2. Based on SDS-PAGE, the purity of the recombinant protein exceeds 90%.

Data Sheets:
-    8CP2 Recombinant canine parvovirus VP2, antigen
-    3PV16 Canine parvovirus, antibody